This message contains My NCBI what's new results from the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NLM).
Do not reply directly to this message.
Sender's message:
Sent on Friday, 2009 Jul 31Search kinetoplastids OR kinetoplastid OR Kinetoplastida OR "trypanosoma brucei" OR leishmania OR brucei OR leishmaniasis OR "African trypanosomiasis"
Click here to view complete results in PubMed. (Results may change over time.)
To unsubscribe from these e-mail updates click here.
PubMed Results |
- 1: FASEB J. 2009 Jul 29. [Epub ahead of print]
-
Signal transducer and activator of transcription 1 in T cells plays an indispensable role in immunity to Leishmania major by mediating Th1 cell homing to the site of infection.
*Department of Microbiology andCenter for Microbial Interface Biology, The Ohio State University, Columbus, Ohio, USA; andDepartment of Pathology, Children's Hospital, Columbus, Ohio, USA.
The signal transducer and activator of transcription 1 (STAT1) signaling pathway mediates the biological functions of IFN-gamma. We have previously shown that the STAT1 pathway is indispensable for host resistance against Leishmania major infection. In this study, we examined the role of STAT1 in lymphocytes and specifically CD4(+) and CD8(+) T cells in mediating immunity against L. major by transferring T cells from wild-type (WT) and STAT1(-/-) C57BL/6 mice into Rag2(-/-) C57BL/6 mice. Rag2(-/-) mice reconstituted with unfractionated STAT1(-/-) splenocytes (B cells and T cells) failed to mount an efficient Th1 response after L. major infection, produced more IL-4, and developed large lesions full of parasites. In contrast, Rag2(-/-) mice reconstituted with WT (STAT1(+/+)) splenocytes mounted a Th1 response and developed self-resolving lesions. Studies using Rag2(-/-) recipients that received a combination of purified CD4(+) and CD8(+) T cells from WT or STAT1(-/-) mice revealed that STAT1 deficiency in CD4(+) T cells, but not in CD8(+) T cells, leads to development of chronic, nonhealing lesions and systemic dissemination of parasites into the spleen after L. major infection. Further studies using Rag2(-/-) recipients of WT Thy1.1(+) and STAT1(-/-) Thy1.2(+) T cells showed that STAT1 in CD4(+) T cells was not required for Th1 differentiation during L. major infection. However, it was critical for up-regulation of CXCR3 on CD4(+) T cells and their migration to the regional lymph node and the cutaneous site of infection. Together, these studies indicate that the STAT1 pathway in CD4(+) T cells plays a critical role in immunity against L. major by controlling the migration of Th1 cells to the site of infection rather than their generation. Further, they reveal an essential role for CD4(+) T cell STAT1 in preventing systemic dissemination of L. major infection.-Barbi, J., Snider, H. M., Bardhwaj, N., Lezama-Dávila, C. M., Durbin, J. E., Satoskar, A. R. Signal transducer and activator of transcription 1 in T cells plays an indispensable role in immunity to Leishmania major by mediating Th1 cell homing to the site of infection.
PMID: 19641143 [PubMed - as supplied by publisher]
-
Related articles
- STAT1 expression in dendritic cells, but not T cells, is required for immunity to Leishmania major.
J Immunol. 2007 Jun 1; 178(11):7259-66.
[J Immunol. 2007]
- Development of protective immunity against cutaneous leishmaniasis is dependent on STAT1-mediated IFN signaling pathway.
Eur J Immunol. 2003 Jul; 33(7):1799-805.
[Eur J Immunol. 2003]
- CXCR3-/- mice mount an efficient Th1 response but fail to control Leishmania major infection.
Eur J Immunol. 2005 Feb; 35(2):515-23.
[Eur J Immunol. 2005]
- ReviewAnti-leishmania effector functions of CD4+ Th1 cells and early events instructing Th2 cell development and susceptibility to Leishmania major in BALB/c mice.
Adv Exp Med Biol. 1998; 452:53-60.
[Adv Exp Med Biol. 1998]
- ReviewCytokines in parasitic diseases: the example of cutaneous leishmaniasis.
Int Rev Immunol. 1998; 17(1-4):157-80.
[Int Rev Immunol. 1998]
- » See reviews... | » See all...
- STAT1 expression in dendritic cells, but not T cells, is required for immunity to Leishmania major.
- 2: Annu Rev Genet. 2009 Jul 29. [Epub ahead of print]
-
Genetic and Epigenetic Mechanisms Underlying Cell-Surface Variability in Protozoa and Fungi.
1Laboratory for Systems Biology, VIB, B-3001 Leuven, Belgium and Centre of Microbial and Plant Genetics (CMPG), Genetics and Genomics Group, Department of Molecular and Microbial Systems, K.U. Leuven, Faculty of Applied Bioscience and Engineering, B-3001 Leuven, Belgium; email: kevin.verstrepen@biw.kuleuven.be.
Eukaryotic microorganisms have evolved ingenious mechanisms to generate variability at their cell surface, permitting differential adherence, rapid adaptation to changing environments, and evasion of immune surveillance. Fungi such as Saccharomyces cerevisiae and the pathogen, Candida albicans carry a family of mucin and adhesin genes that allow adhesion to various surfaces and tissues. Trypanosoma cruzi, T. brucei, and Plasmodium falciparum likewise contain large arsenals of different cell surface adhesion genes. In both yeasts and protozoa, silencing and differential expression of the gene family results in surface variability. Here, we discuss unexpected similarities in the structure and genomic location of the cell surface genes, the role of repeated DNA sequences, and the genetic and epigenetic mechanisms-all of which contribute to the remarkable cell surface variability in these highly divergent microbes. Expected final online publication date for the Annual Review of Genetics Volume 43 is October 28, 2009. Please see http://www.annualreviews.org/catalog/pubdates.aspx for revised estimates.
PMID: 19640229 [PubMed - as supplied by publisher]
-
Related articles
- Regressive Evolution in Astyanax Cavefish.
Annu Rev Genet. 2009 Jul 29; . Epub 2009 Jul 29.
[Annu Rev Genet. 2009]
- Inherited Variation in Gene Expression.
Annu Rev Genomics Hum Genet. 2009 Jul 16; . Epub 2009 Jul 16.
[Annu Rev Genomics Hum Genet. 2009]
- Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration.
Annu Rev Genomics Hum Genet. 2009 Apr 29; . Epub 2009 Apr 29.
[Annu Rev Genomics Hum Genet. 2009]
- ReviewDNA metabolism and genetic diversity in Trypanosomes.
Mutat Res. 2006 Jan; 612(1):40-57. Epub 2005 Jul 22.
[Mutat Res. 2006]
- ReviewVariability and exclusion in host and parasite: epigenetic regulation of Ig and var expression.
J Immunol. 2006 Nov 1; 177(9):5767-74.
[J Immunol. 2006]
- » See reviews... | » See all...
- Regressive Evolution in Astyanax Cavefish.
- 3: J Drug Target. 2009 Jul 29. [Epub ahead of print]
-
In vitro evaluation of surface functionalized gelatin nanoparticles for macrophage targeting in the therapy of visceral leishmaniasis.
Department of Pharmaceutical Sciences, Dr. H. S. Gour University, Sagar, India.
The present study evaluates the potential of surface functionalized gelatin nanoparticles (f-GNPs) for efficient macrophage-specific delivery of amphotericin B (AmB) in the treatment of visceral leishmaniasis (VL). Further, the effect of spacer for macrophage targeting was also evaluated. Gelatin was functionalized either through conjugation to mannose via direct coupling (mGelatin) or via PEG spacer (m-Gelatin), and the synthesis was confirmed by FTIR. AmB-loaded f-GNPs, that is, mGNPs and m-GNPs prepared from mGelatin and m-Gelatin conjugates, respectively, were characterized. In vitro concanavalin A (Con-A) agglutination assay confirmed the availability of mannose on the surface of these f-GNPs. Kinetics of cellular uptake of AmB-loaded f-GNPs by J774A.1 macrophage cells assessed through flow cytometry demonstrated a steady increase and maximum cell-associated fluorescence was observed at 4h for m-GNPs and 6 h for m-GNPs. Measurement of cytotoxicity using Annexin-V-FITC/PI apoptosis assay delineated marginal changes (7-9%) in treated macrophages following 48 h incubation, establishing the safety of f-GNPs. m-GNPs showed a 5.4-fold reduction in IC(50) in comparison with plain AmB suggesting significant enhancement of antileishmanial activity. Our results indicate that f-GNPs could be a promising carrier for specific delivery of AmB to macrophages for effective treatment of VL. Furthermore, spacer contributed significantly in reducing the cytotoxicity as well as increasing the uptake and activity of f-GNPs.
PMID: 19640212 [PubMed - as supplied by publisher]
-
Related articles
- Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles.
Nanomedicine. 2008 Sep; 4(3):252-61. Epub 2008 May 23.
[Nanomedicine. 2008]
- Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis.
J Drug Target. 2007 Jul; 15(6):437-44.
[J Drug Target. 2007]
- Development and characterization of amphotericin B bearing emulsomes for passive and active macrophage targeting.
J Drug Target. 2007 Apr; 15(3):206-17.
[J Drug Target. 2007]
- Review[Change in human visceral leishmaniasis treatment in Italy: retrospective study of 630 patients]
Parassitologia. 2004 Jun; 46(1-2):199-201.
[Parassitologia. 2004]
- ReviewAmphotericin-B colloidal dispersion. A review of its use against systemic fungal infections and visceral leishmaniasis.
Drugs. 1998 Sep; 56(3):365-83.
[Drugs. 1998]
- » See reviews... | » See all...
Patient Drug Information
- Docusate (Docusate calcium, Stool softener, Sulfolax, ...)
How do the drugs used to treat chronic constipation and irritable bowel syndrome with predominant constipation compare?
- Development, characterization, and toxicity evaluation of amphotericin B-loaded gelatin nanoparticles.
- 4: Med Trop (Mars). 2008 Dec;68(6):634-6.
-
[Mucosal leishmaniasis by contiguity with a skin lesion: another case report from Tunisia]
[Article in French]Service de dermatologie, Hôpital Charles Nicolle, Tunis, Tunisie. fekih.nadia@planet.tn
Three clinical forms of cutaneous leishmaniasis can be found in Tunisia, i.e. the sporadic form due to Leishmania infantum in the North, the zoonotic epidemic form due to Leishmania major in the center and Southwest, and the chronic cutaneous form due to Leishmania tropica in the South. Unlike cutaneous forms, mucosal involvement is uncommon. The purpose of this report is to describe another case of mucosal leishmaniasis due to contiguity with a skin lesion in a 54-years-old woman. The patient responded well to treatment with meglumine antimoniate.
PMID: 19639835 [PubMed - in process]
-
Related articles
- [Mucosal localization of leishmaniasis in Tunisia: 5 cases]
Ann Dermatol Venereol. 2003 Jan; 130(1 Pt 1):27-30.
[Ann Dermatol Venereol. 2003]
- [Cutaneous leishmaniasis caused by Leishmania infantum MON-24 in Tunisia: extension of the focus to the center of the country]
Bull Soc Pathol Exot. 2008 Feb; 101(1):29-31.
[Bull Soc Pathol Exot. 2008]
- Cutaneous leishmaniasis in Tunisia: results of the iso-enzymatic characterization of 71 strains.
Ann Trop Med Parasitol. 2005 Jan; 99(1):11-9.
[Ann Trop Med Parasitol. 2005]
- ReviewLocalized Leishmaniasis of the oral mucosa. A report of three cases.
Med Oral Patol Oral Cir Bucal. 2007 Aug 1; 12(4):E281-6. Epub 2007 Aug 1.
[Med Oral Patol Oral Cir Bucal. 2007]
- Review[Management of cutaneous leishmaniasis in adults and children]
Med Trop (Mars). 2005 Nov; 65(5):487-95.
[Med Trop (Mars). 2005]
- » See reviews... | » See all...
- [Mucosal localization of leishmaniasis in Tunisia: 5 cases]
- 5: Med Trop (Mars). 2008 Dec;68(6):584-5.
-
[Treatment of leishmaniasis: Institut Pasteur, Paris, November 19, 2008]
[Article in French]Service de biologie médicale, Hôpital d'Instruction des Armées Bégin, St Mandé, France. janvierfred@hotmail.com
PMID: 19639821 [PubMed - in process]
-
Related articles
- [The institut Pasteur de Paris at the Journée de la Recherche.]
Union Med Can. 1951 Feb; 80(2):226-8.
[Union Med Can. 1951]
- The designing of anti-diphtheria serotherapy at the Institut Pasteur (1888-1900): the role of a supranational network of microbiologists.
Dynamis. 2007; 27:45-62.
[Dynamis. 2007]
- [Historical note on the discovery of cutaneous leishmaniasis transmission by Phlebotomus]
Bull Soc Pathol Exot. 1997; 90(3):177-8.
[Bull Soc Pathol Exot. 1997]
- ReviewConsensus Conference: management of chronic urticaria. Wednesday 8 January 2003. Institut Pasteur-Paris, France. Recommendations (short version).
Eur J Dermatol. 2003 Jul-Aug; 13(4):385-92.
[Eur J Dermatol. 2003]
- ReviewInstitut Pasteur v. United States: the AIDS patent dispute, the Contract Disputes Act and the international exchange of scientific data.
Am J Law Med. 1989; 15(4):439-59.
[Am J Law Med. 1989]
- » See reviews... | » See all...
- [The institut Pasteur de Paris at the Journée de la Recherche.]
No comments:
Post a Comment